Zai Lab (ZLAB) Non-Current Assets (2016 - 2026)
Zai Lab (ZLAB) reported Non-Current Assets of $151.0 million for Q1 2026, up 14.87% on a YoY basis from $131.5 million in Q1 2025, and down 1.37% sequentially from $153.1 million in Q4 2025.
Zai Lab (ZLAB) Non-Current Assets (2016 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 11 years of Non-Current Assets data on file, last reported at $151.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 14.87% year-over-year to $151.0 million; the trailing twelve-month figure through Mar 2026 stood at $560.1 million (up 10.05% YoY), and the FY2025 full-year result was $153.1 million, up 13.18% from the prior year.
- Non-Current Assets slipped to $151.0 million in Q1 2026, from $153.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $153.1 million in Q4 2025 to a low of $83.1 million in Q2 2022.
- A 5-year average of $112.4 million and a median of $107.7 million in 2022 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets fell 18.63% in 2022 and surged 48.63% in 2024, its largest moves.
- Tracing ZLAB's Non-Current Assets over 5 years: stood at $95.8 million in 2022, then grew by 0.92% to $96.7 million in 2023, then surged by 39.91% to $135.3 million in 2024, then advanced by 13.18% to $153.1 million in 2025, then retreated by 1.37% to $151.0 million in 2026.
- Business Quant data shows ZLAB's Non-Current Assets at $151.0 million in Q1 2026, $153.1 million in Q4 2025, and $126.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 5.83 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.95 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 285.82 Mn |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | 151.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.01 Mn |
| Dec 31, 2025 | 153.10 Mn |
| Sep 30, 2025 | 125.99 Mn |
| Jun 30, 2025 | 130.04 Mn |
| Mar 31, 2025 | 131.46 Mn |
| Dec 31, 2024 | 135.27 Mn |
| Sep 30, 2024 | 124.80 Mn |
| Jun 30, 2024 | 117.45 Mn |
| Mar 31, 2024 | 99.80 Mn |
| Dec 31, 2023 | 96.69 Mn |
| Sep 30, 2023 | 83.96 Mn |
| Jun 30, 2023 | 88.87 Mn |
| Mar 31, 2023 | 97.78 Mn |
| Dec 31, 2022 | 95.80 Mn |
| Sep 30, 2022 | 88.68 Mn |
| Jun 30, 2022 | 83.13 Mn |
| Mar 31, 2022 | 107.66 Mn |
| Dec 31, 2021 | 109.08 Mn |
| Sep 30, 2021 | 108.99 Mn |
| Jun 30, 2021 | 86.61 Mn |